Achiko Logo cropped.jpg
Achiko AG Appoints New Chief Financial Officer
October 07, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare...
Achiko Logo cropped.jpg
Achiko AG – Investor Briefing
July 07, 2022 15:22 ET | Achiko AG
ZURICH, Switzerland, July 07, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF, SIX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a...
Achiko Logo cropped.jpg
Achiko AG Announces Annual Results for the Year Ended December 31, 2021
June 26, 2022 19:30 ET | Achiko AG
ZURICH, Switzerland, June 26, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces its financial results for the year ended December...
Achiko Logo cropped.jpg
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by June 26, 2022
June 20, 2022 20:24 ET | Achiko AG
ZURICH, Switzerland, June 20, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...
Achiko Logo cropped.jpg
Achiko AG Publication of Annual Report and Annual Financial Statements 2021 to Occur by June 6, 2022
May 31, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, May 31, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...
Achiko Logo cropped.jpg
Achiko Secures $1.3 Million Financing with Strategic Investors Buranto AG and Negma Group
May 25, 2022 07:30 ET | Achiko AG
Buranto AG Provided a USD$260,000 (CHF 250,000) Loan Facility and Existing Strategic Investor Negma Group Provided a USD$1.04 Million (CHF 1.0 Million) Loan FacilityDerek Brandt, Co-owner of Buranto...
Achiko Logo cropped.jpg
Achiko AG Obtains CE Mark for AptameX™ Covid-19 Rapid Test
May 17, 2022 07:30 ET | Achiko AG
Registered AptameX and Has Obtained a CE Mark, Allowing the Product to Be Sold in 27 Countries in the EUAptameX Has Unique Performance Advantages Over Other Rapid Tests Through its Use of DNA...
Achiko Logo cropped.jpg
AptameX Production and Commercialization Update
April 28, 2022 08:15 ET | Achiko AG
Company has commenced shipping and will book first sales in May 2022Reorganized production line able to meet stronger than expected demand for Achiko AG’s innovative DNA aptamer saliva-based rapid...
Achiko Logo cropped.jpg
Achiko AG Signs Major Marketing and Sales Agreement with World’s Largest Islamic Association for its AptameX Covid-19 Rapid Test
April 20, 2022 07:45 ET | Achiko AG
Signed major deal with Pengurus Wilayah Nahdlatul Ulama DKI Jakarta, for the use of Covid-19 test AptameX in general assemblies and activities. Located primarily in Indonesia, Nahdlatul Ulama is the...
Achiko Logo cropped.jpg
Achiko Secures up to USD$12.6 Million Equity and Debt Financing Lines with RiverFort Over Three Years
April 20, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, April 20, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces the...